Ticker Details
AquaBounty Technologies, Inc. AquaBounty Technologies Inc is a biotechnology company. The company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins.
IPO Date:	January 9, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.37M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 4.00%
Avg Daily Range (30 D):	$0.04 | 3.94%
Avg Daily Range (90 D):	$0.04 | 3.72%

Institutional Daily Volume
Avg Daily Volume:	.18M
Avg Daily Volume (30 D):	.03M
Avg Daily Volume (90 D):	.04M

Trade Size
Avg Trade Size (Sh.):	66
Avg Trade Size (Sh.) (30 D):	200
Avg Trade Size (Sh.) (90 D):	222

Institutional Trades
Total Institutional Trades:	125
Avg Institutional Trade:	$1.52M
Avg Institutional Trade (30 D):	$.52M
Avg Institutional Trade (90 D):	$.52M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.13M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	21.76K

News

Aug 25, 2025 @ 12:00 PM Shenandoah Telecommunications Appoints Angela M. O... Source: Angela M. Olsen

May 15, 2024 @ 2:20 PM AquaBounty Technologies, Inc. (AQB) Reports Q1 Los... Source: Zacks Equity Research

May 14, 2024 @ 1:10 PM Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Reve... Source: Zacks Equity Research

May 13, 2024 @ 9:10 PM Cara Therapeutics (CARA) Reports Q1 Loss, Misses R... Source: Zacks Equity Research

May 8, 2024 @ 9:45 PM Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, To... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-22.9	$-.36	$-.87
Diluted EPS	$-22.9	$-.36	$-.87
Revenue	$-.71M	$M	$M
Gross Profit
Net Income / Loss	$-88.47M	$-1.38M	$-3.37M
Operating Income / Loss	$-83.77M	$-1.48M	$-3.29M
Cost of Revenue
Net Cash Flow	$.45M	$.22M	$-.64M
PE Ratio

Splits
Oct 16, 2023	1:20
Jan 05, 2017	1:30